|
⚲
|
| Handa Pharmaceuticals LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001460459 |
| Sale | 2009-03-16 ($0.0 M Offered, $0.0 M Sold) |
| Fund | |
| Phone | 5103542888 |
| Address | 39465 Paseo Padre Parkway Fremont, 94538 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Meifang Chang | |
| Jonathan Embleton | |
| Stephen Cary | |
| Fangyu Liu |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
EasyG, LLC
✚
|
0.0 | |
|
Yousif Paul
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 788
✚
|
0.0 | |
|
ESW Capital, LLC
✚
|
0.0 | |
|
Etebase Inc.
✚
|
0.0 | |
|
ET Fund I, a series of January Ventures, LP
✚
|
0.0 | |
|
ET Fund II, a series of SOGALFEMPIRE, LP
✚
|
0.0 | |
|
Ethan DD W21, a series of Ethan Perlstein Funds, LP
✚
|
0.0 | |
|
Ethereal Ventures Fund I L.P.
✚
|
0.0 | |
|
Smartwyre Inc.
✚
|
0.0 |